189 related articles for article (PubMed ID: 8951616)
1. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties.
Shibuya-Saruta H; Kasahara Y; Hashimoto Y
J Clin Lab Anal; 1996; 10(6):435-40. PubMed ID: 8951616
[TBL] [Abstract][Full Text] [Related]
2. Colorimetrical rate assay for urinary dipeptidyl peptidase IV (DPPIV) activity using a new substrate.
Shibuya-Saruta H; Sugiyama M; Kasahara Y
J Clin Lab Anal; 1995; 9(2):113-8. PubMed ID: 7714663
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of a Z-pro-prolinal-insensitive Z-Gly-Pro-7-amino-4-methyl coumarin-hydrolyzing peptidase from bovine serum--a new proline-specific peptidase.
Birney YA; O'Connor BF
Protein Expr Purif; 2001 Jul; 22(2):286-98. PubMed ID: 11437605
[TBL] [Abstract][Full Text] [Related]
4. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
[TBL] [Abstract][Full Text] [Related]
5. Peptide truncation by dipeptidyl peptidase IV: a new pathway for drug discovery?
Scharpé S; De Meester I
Verh K Acad Geneeskd Belg; 2001; 63(1):5-32; discussion 32-3. PubMed ID: 11284388
[TBL] [Abstract][Full Text] [Related]
6. An assay of dipeptidyl peptidase IV activity in human serum and serum of pregnant women with glycyl-L-proline-1-naphthylamide and other glycyl-L-proline-arylamides as substrates.
Krepela E; Kasafírek E; Vicar J; Kraml J
Physiol Bohemoslov; 1983; 32(4):334-45. PubMed ID: 6353449
[TBL] [Abstract][Full Text] [Related]
7. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
[TBL] [Abstract][Full Text] [Related]
8. Purification and properties of human placental dipeptidyl peptidase IV.
Mizutani S; Sumi S; Narita O; Tomoda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):769-75. PubMed ID: 2860191
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of two molecular forms of dipeptidyl peptidase IV in normal human serum.
Krepela E; Kraml J; Vicar J; Kadlecová L; Kasafírek E
Physiol Bohemoslov; 1983; 32(6):486-96. PubMed ID: 6366838
[TBL] [Abstract][Full Text] [Related]
10. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.
Kobayashi H; Hosono O; Mimori T; Kawasaki H; Dang NH; Tanaka H; Morimoto C
J Rheumatol; 2002 Sep; 29(9):1858-66. PubMed ID: 12233879
[TBL] [Abstract][Full Text] [Related]
11. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells.
Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF
J Immunol; 1996 Mar; 156(5):1714-21. PubMed ID: 8596018
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of dipeptidyl peptidase IV from Streptococcus salivarius HHT.
Mineyama R; Saito K
Microbios; 1991; 67(274):37-52. PubMed ID: 1684633
[TBL] [Abstract][Full Text] [Related]
13. Application of the dipeptidyl peptidase IV (DPPIV/CD26) based prodrug approach to different amine-containing drugs.
Diez-Torrubia A; García-Aparicio C; Cabrera S; De Meester I; Balzarini J; Camarasa MJ; Velázquez S
J Med Chem; 2010 Jan; 53(2):559-72. PubMed ID: 20000418
[TBL] [Abstract][Full Text] [Related]
14. A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26).
Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF
J Biol Chem; 1995 Jun; 270(23):14107-14. PubMed ID: 7539799
[TBL] [Abstract][Full Text] [Related]
15. Characterization of dipeptidyl peptidase IV from lymphocytes of chronic lymphocytic leukemia of T-type.
Mentlein R; Rix H; Feller AC; Heymann E
Biomed Biochim Acta; 1986; 45(5):567-74. PubMed ID: 2875712
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
Durinx C; Lambeir AM; Bosmans E; Falmagne JB; Berghmans R; Haemers A; Scharpé S; De Meester I
Eur J Biochem; 2000 Sep; 267(17):5608-13. PubMed ID: 10951221
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides.
Coutts SJ; Kelly TA; Snow RJ; Kennedy CA; Barton RW; Adams J; Krolikowski DA; Freeman DM; Campbell SJ; Ksiazek JF; Bachovchin WW
J Med Chem; 1996 May; 39(10):2087-94. PubMed ID: 8642568
[TBL] [Abstract][Full Text] [Related]
18. Contamination of highly purified human serum cholinesterase by dipeptidyl peptidase IV causing hydrolysis of substance P.
Kaemmer D; Neubert K; Demuth HU; Barth A
Pharmazie; 1986 Jul; 41(7):494-6. PubMed ID: 2430307
[TBL] [Abstract][Full Text] [Related]
19. Stepwise degradation of the hexapeptide Met-Ala-Ser-Pro-Phe-Ala by dipeptidyl peptidase IV.
Berger E; Fischer G; Neubert K; Barth A
Biomed Biochim Acta; 1987; 46(10):671-6. PubMed ID: 2895640
[TBL] [Abstract][Full Text] [Related]
20. The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with diprotin A.
Hiramatsu H; Yamamoto A; Kyono K; Higashiyama Y; Fukushima C; Shima H; Sugiyama S; Inaka K; Shimizu R
Biol Chem; 2004 Jun; 385(6):561-4. PubMed ID: 15255191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
